A Case Report of Mesothelioma Response to Endocrine Therapy in Synchronous Breast Cancer and Pleural Epithelioid Mesothelioma: A Double Exemestane Effect-Reference-Cited by-同舟云学术

A Case Report of Mesothelioma Response to Endocrine Therapy in Synchronous Breast Cancer and Pleural Epithelioid Mesothelioma: A Double Exemestane Effect

Published:2022-11-16 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Pina Marta,Fernandes Rute,Fonseca Diogo,Oliveira Cristina,Rodrigues Ana

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference13 articles.

1. Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease;Nuvoli B;Mol Cancer,2014

2. Epidemiology of mesothelioma in the 21st century in Europe and the United States, 40 years after restricted/banned asbestos use;Alpert N;Transl Lung Cancer Res,2020

3. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆;Popat S;Ann Oncol,2022

4. An association between postoperative radiotherapy for primary breast cancer in 11 National Surgical Adjuvant Breast and Bowel Project (NSABP) studies and the subsequent appearance of pleural mesothelioma;Deutsch M;Am J Clin Oncol,2007

5. Synchronous diffuse malignant mesothelioma and carcinomas in asbestos-exposed individuals;Attanoos RL;Histopathology,2003

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DHEA-S, Androstenedione, 17-β-estradiol signature as novel biomarkers for early prediction of risk of malignant pleural mesothelioma linked to asbestos-exposure: A preliminary investigation;Biomedicine & Pharmacotherapy;2024-06